These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 16753828)
41. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
42. Preparation of itraconazole-loaded liposomes coated by carboxymethyl chitosan and its pharmacokinetics and tissue distribution. Wang J; Huang G Drug Deliv; 2011 Nov; 18(8):631-8. PubMed ID: 22111976 [TBL] [Abstract][Full Text] [Related]
43. Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins. Sinswat P; Tengamnuay P Int J Pharm; 2003 May; 257(1-2):15-22. PubMed ID: 12711157 [TBL] [Abstract][Full Text] [Related]
44. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery. Garcia-Fuentes M; Prego C; Torres D; Alonso MJ Eur J Pharm Sci; 2005 May; 25(1):133-43. PubMed ID: 15854809 [TBL] [Abstract][Full Text] [Related]
46. Methylated N-(4-N,N-dimethylaminobenzyl) chitosan coated liposomes for oral protein drug delivery. Kowapradit J; Apirakaramwong A; Ngawhirunpat T; Rojanarata T; Sajomsang W; Opanasopit P Eur J Pharm Sci; 2012 Sep; 47(2):359-66. PubMed ID: 22771544 [TBL] [Abstract][Full Text] [Related]
47. Transmucosal macromolecular drug delivery. Prego C; García M; Torres D; Alonso MJ J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901 [TBL] [Abstract][Full Text] [Related]
48. Oral delivery of synthetic eel calcitonin, elcatonin, in rats. Ogiso T; Funahashi N; Tsukioka Y; Iwaki M; Tanino T; Wada T Biol Pharm Bull; 2001 Jun; 24(6):656-61. PubMed ID: 11411554 [TBL] [Abstract][Full Text] [Related]
49. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation. Fan B; Xing Y; Zheng Y; Sun C; Liang G Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290 [TBL] [Abstract][Full Text] [Related]
50. Chitosan-coated nano-liposomes for the oral delivery of berberine hydrochloride. Nguyen TX; Huang L; Liu L; Elamin Abdalla AM; Gauthier M; Yang G J Mater Chem B; 2014 Nov; 2(41):7149-7159. PubMed ID: 32261793 [TBL] [Abstract][Full Text] [Related]
51. Use of novel taurine-chitosan mediated liposomes for enhancing the oral absorption of doxorubicin via the TAUT transporter. Qin S; Wen Z; Huang H; Wu W Carbohydr Polym; 2024 Apr; 329():121780. PubMed ID: 38286550 [TBL] [Abstract][Full Text] [Related]
52. Carbopol-lectin conjugate coated liposomes for oral peptide delivery. Werle M; Makhlof A; Takeuchi H Chem Pharm Bull (Tokyo); 2010 Mar; 58(3):432-4. PubMed ID: 20190459 [TBL] [Abstract][Full Text] [Related]
53. The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system. Chen H; Pan H; Li P; Wang H; Wang X; Pan W; Yuan Y Colloids Surf B Biointerfaces; 2016 Jul; 143():455-462. PubMed ID: 27037783 [TBL] [Abstract][Full Text] [Related]
54. Polymer coated liposomes for use in the oral cavity - a study of the in vitro toxicity, effect on cell permeability and interaction with mucin. Klemetsrud T; Kjøniksen AL; Hiorth M; Jacobsen J; Smistad G J Liposome Res; 2018 Mar; 28(1):62-73. PubMed ID: 27809639 [TBL] [Abstract][Full Text] [Related]
55. Chitosan coated vancomycin hydrochloride liposomes: Characterizations and evaluation. Yang Z; Liu J; Gao J; Chen S; Huang G Int J Pharm; 2015 Nov; 495(1):508-515. PubMed ID: 26325316 [TBL] [Abstract][Full Text] [Related]
56. Chitosan-modified cholesterol-free liposomes for improving the oral bioavailability of progesterone. Wang M; Liu M; Xie T; Zhang BF; Gao XL Colloids Surf B Biointerfaces; 2017 Nov; 159():580-585. PubMed ID: 28854414 [TBL] [Abstract][Full Text] [Related]
57. Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride. du Plessis LH; Lubbe J; Strauss T; Kotzé AF Int J Pharm; 2010 Jan; 385(1-2):181-6. PubMed ID: 19854253 [TBL] [Abstract][Full Text] [Related]
58. In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery. Makhlof A; Fujimoto S; Tozuka Y; Takeuchi H Eur J Pharm Biopharm; 2011 Feb; 77(2):216-24. PubMed ID: 21147220 [TBL] [Abstract][Full Text] [Related]
59. [Effects of the liposomes coated by chitosan and its derivatives on the gastrointestinal transit of insulin]. Wu ZH; Ping QN; Lei XM; Li JY; Cai P Yao Xue Xue Bao; 2005 Jul; 40(7):618-22. PubMed ID: 16196267 [TBL] [Abstract][Full Text] [Related]
60. Protection of dopamine towards autoxidation reaction by encapsulation into non-coated- or chitosan- or thiolated chitosan-coated-liposomes. Trapani A; Mandracchia D; Tripodo G; Cometa S; Cellamare S; De Giglio E; Klepetsanis P; Antimisiaris SG Colloids Surf B Biointerfaces; 2018 Oct; 170():11-19. PubMed ID: 29859476 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]